Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese - 12-Year prospective cohort study

Circulation Journal

Volumn 73, Issue 8, 2009, Pages 1423-1430

  Sun, Yu ^a   Chien, Kuo Liong ^a,b   Hsu, Hsiu Ching ^b   Su, Ta Chen ^b   Chen, Ming Fong ^b   Lee, Yuan Teh ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Coronary heart disease; Cutpoint; Homocysteine; Mortality; Stroke

Indexed keywords

HOMOCYSTEINE;

ADULT; ARTICLE; CHINESE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; DEATH; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SERUM; STROKE; VASCULAR DISEASE;

ADULT; AGED; CHINA; COHORT STUDIES; CORONARY DISEASE; DEATH; HOMOCYSTEINE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; ROC CURVE; STROKE;

EID: 69049106721     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1077     Document Type: Article

References (45)

1. Christen WG, Ajani UA, Glynn RJ, Hennekens CH. Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual? Arch Intern Med 2000; 160: 422-434.
2. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002; 288: 2015-2022. (Pubitemid 35204692)
3. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study. Ann Intern Med 1999; 131: 352-355. (Pubitemid 29424629)
4. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: The NOrthern MAnhattan Study. Stroke 2004; 35: 2263-2269.
5. Fallon UB, Elwood P, Ben-Shlomo Y, Ubbink JB, Greenwood R, Smith GD. Homocysteine and ischaemic stroke in men: The Caerphilly study. J Epidemiol Community Health 2001; 55: 91-96. (Pubitemid 32095194)
6. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994; 106: 9-19. (Pubitemid 24103795)
7. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998; 98: 204-210.
8. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA 1999; 281: 1817-1821. (Pubitemid 29231132)
9. Zylberstein DE, Bengtsson C, Bjorkelund C, Landaas S, Sundh V, Thelle D, et al. Serum homocysteine in relation to mortality and morbidity from coronary heart disease: A 24-year follow-up of the population study of women in Gothenburg. Circulation 2004; 109: 601-606. (Pubitemid 38198867)
10. Stehouwer CD, Weijenberg MP, van den Berg M, Jakobs C, Feskens EJ, Kromhout D. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: A 10-year follow-up. Arterioscler Thromb Vasc Biol 1998; 18: 1895-1901. (Pubitemid 28565751)
11. Rossi GP, Maiolino G, Seccia TM, Burlina A, Zavattiero S, Cesari M, et al. Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. J Hypertens 2006; 24: 851-859. (Pubitemid 43670455)
12. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-236. (Pubitemid 27310438)
13. Ndrepepa G, Kastrati A, Braun S, Koch W, Kolling K, Mehilli J, et al. A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease. Clin Chim Acta 2006; 373: 70-76. (Pubitemid 44308543)
14. Soinio M, Marniemi J, Laakso M, Lehto S, Ronnemaa T. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med 2004; 140: 94-100. (Pubitemid 38095404)
15. Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation 2008; 117: 1787-1801.
16. Japan Arteriosclerosis Longitudinal Study (JALS) Group. Japan Arteriosclerosis Longitudinal Study-Existing Cohorts Combine (JALS-ECC): Rationale, design, and population characteristics. Circ J 2008; 72: 1563-1568.
17. Ohsawa M, Okayama A, Okamura T, Itai K, Nakamura M, Tanno K, et al. Mortality risk attributable to atrial fibrillation in middle-aged and elderly people in the Japanese general population: Nineteen-year follow-up in NIPPON DATA80. Circ J 2007; 71: 814-819. (Pubitemid 46833916)
18. Castanon MM, Lauricella AM, Kordich L, Quintana I. Plasma homocysteine cutoff values for venous thrombosis. Clin Chem Lab Med 2007; 45: 232-236. (Pubitemid 46294689)
19. Lee Y, Lin RS, Sung FC, Yang C, Chien K, Chen W, et al. Chin-Shan Community Cardiovascular Cohort in Taiwan: Baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 2000; 53: 838-846. (Pubitemid 30609649)
20. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Incidence of hypertension and risk of cardiovascular events among ethnic Chinese: Report from a community-based cohort study in Taiwan. J Hypertens 2007; 25: 1355-1361.
21. Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT, et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 2008; 54: 310-316. (Pubitemid 351302633)
22. Chien KL, Sung FC, Hsu HC, Su TC, Lin RS, Lee YT. Apolipoprotein A-I and B and stroke events in a community-based cohort in Taiwan: Report of the Chin-Shan Community Cardiovascular Study. Stroke 2002; 33: 39-44.
23. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Metabolic syndrome as a risk factor for coronary heart disease and stroke: An 11-year prospective cohort in Taiwan community. Atherosclerosis 2007; 194: 214-221.
24. Chien KL, Sung FC, Hsu HC, Su TC, Chang WD, Lee YT. Relative importance of atherosclerotic risk factors for coronary heart disease in Taiwan. Eur J Cardiovasc Prev Rehabil 2005; 12: 95-101. (Pubitemid 40571523)
25. Chien KL, Lee YT, Sung FC, Hsu HC, Su TC, Lin RS. Hyperinsulinemia and related atherosclerotic risk factors in the population at cardiovascular risk: A community-based study. Clin Chem 1999; 45: 838-846.
26. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995; 41: 991-994.
27. Chao CL, Kuo TL, Lee YT. Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults. Circulation 2000; 101: 485-490.
28. Refsum H, Ueland PM, Svardal AM. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 1989; 35: 1921-1927. (Pubitemid 19242232)
29. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172; discussion 207-212.
30. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-e146.
31. Bots ML, Launer LJ, Lindemans J, Hoes AW, Hofman A, Witteman JC, et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: The Rotterdam Study. Arch Intern Med 1999; 159: 38-44. (Pubitemid 29044117)
32. Lindgren A, Brattstrom L, Norrving B, Hultberg B, Andersson A, Johansson BB. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 1995; 26: 795-800.
33. Gatt A, Makris M. Hyperhomocysteinemia and venous thrombosis. Semin Hematol 2007; 44: 70-76.
34. Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, et al. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 2003; 34: 632-636. (Pubitemid 36307383)
35. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000; 31: 1069-1075. (Pubitemid 30253527)
36. Shimizu H, Kiyohara Y, Kato I, Tanizaki Y, Ueno H, Kimura Y, et al. Plasma homocyst(e)ine concentrations and the risk of subtypes of cerebral infarction: The Hisayama study. Cerebrovasc Dis 2002; 13: 9-15.
37. Bautista LE, Arenas IA, Penuela A, Martinez LX. Total plasma homocysteine level and risk of cardiovascular disease: A meta-analysis of prospective cohort studies. J Clin Epidemiol 2002; 55: 882-887. (Pubitemid 35246558)
38. Nagai Y, Tasaki H, Miyamoto M, Nihei S, Kobayashi K, Yamashita K, et al. Plasma level of homocysteine is inversely-associated with the development of collateral circulation in patients with single-vessel coronary artery disease. Circ J 2002; 66: 158-162. (Pubitemid 34464722)
39. Sayar N, Terzi S, Bilsel T, Yilmaz HY, Orhan L, Cakmak N, et al. Plasma homocysteine concentration in patients with poor or good coronary collaterals. Circ J 2007; 71: 266-270. (Pubitemid 46182703)
40. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155.
41. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease: Results of a prospective study with implications regarding prevention. Arch Intern Med 1998; 158: 862-867. (Pubitemid 28183640)
42. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999; 99: 178-182. (Pubitemid 29035977)
43. Leeflang MM, Moons KG, Reitsma JB, Zwinderman AH. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: Mechanisms, magnitude, and solutions. Clin Chem 2008; 54: 729-737.
44. Clarke R, Lewington S, Donald A, Johnston C, Refsum H, Stratton I, et al. Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J Cardiovasc Risk 2001; 8: 363-369. (Pubitemid 34107234)
45. Pezzini A, Del Zotto E, Padovani A. Homocysteine and cerebral ischemia: Pathogenic and therapeutical implications. Curr Med Chem 2007; 14: 249-263. (Pubitemid 46299695)